Amagasaki, Japan

Toshikazu Hakogi

This inventor holds 1 USPTO granted patent. Top assignee: Shionogi & Co., Ltd.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Toshikazu Hakogi. Retrieved from https://idiyas.com/inventor/toshikazu-hakogi-42xa7882

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Toshikazu Hakogi: Inventor in Pharmaceutical Process Innovation.

Introduction

Toshikazu Hakogi is an inventor associated with Amagasaki, Japan, and Shionogi & Co., Ltd. His patent work concerns a process for preparing intermediates used in the production of substituted polycyclic pyridone derivatives.

Latest Patents

Hakogi is associated with 1 patent: “Stereoselective Process for Preparing Substituted Polycyclic Pyridone.” The invention describes an industrially suitable method for producing intermediates for substituted polycyclic pyridone derivatives with cap-dependent endonuclease inhibitory activity. It uses stereochemistry-controlled intramolecular cyclization to obtain an optically active substituted tricyclic pyridone derivative in high yield and with high enantioselectivity, followed by removal of a functional group from an asymmetric carbon.

Career Highlights

The available information connects Hakogi’s patent activity with Shionogi & Co., Ltd., a pharmaceutical company. His disclosed invention focuses on improving the preparation of a stereochemically defined intermediate relevant to pharmaceutical research and production.

Collaborations

Kazuya Okamoto and Tatsuhiko Ueno are identified as Hakogi’s coworkers. The provided information does not specify their individual roles in the patent or the nature of their collaboration.

Conclusion

Toshikazu Hakogi’s documented patent contribution centers on a stereoselective process designed to support the efficient preparation of pharmaceutical intermediates.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…